All > Mental Illness

PSY-PGx Group for Mood Disorders

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
SUNY Upstate Medical University, Department of Psychiatry and Behavioural Sciences, Syracuse, NYMood Disorders+2 MorePersonalised medication advice based on pharmacogenetic testing - Other
Eligibility
16 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if personalized medicine helps psychiatric patients better than usual treatments.

Eligible Conditions
  • Mood Disorders
  • Anxiety Disorders
  • Psychosis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
SEA-CD70
1
TS-161 (50 - 100 mg)
1
Unaided condition

Study Objectives

2 Primary · 10 Secondary · Reporting Duration: 24 weeks

24 weeks
Burden of side effects, as measured by
General wellbeing, as measured by
Passive behavioral monitoring using the BeHAPP mobile application (Eskes et al. 2016, Mulder et al. 2018, Jagesar et al. 2021).
Passive behavioral monitoring using the BeHAPP mobile application.
Patient recovery as assessed using the patient recovery assessment scale (RAS-DS)
Patient recovery, as assessed using the Patient Recovery Assessment scale - Domains and Stages (RAS-DS).
Psychosocial functioning, as measured by
Response Anxiety Disorder, defined as a 50% point reduction in the following scale
Response Mood Disorder, defined as a 50% point reduction in the following scale
Response Psychotic Disorder, defined as a 50% point reduction in the following scale
Side effects, as measured by
Symptomatic Remission Anxiety Disorder, defined as
Symptomatic Remission Mood Disorder, defined as
Symptomatic Remission Psychotic Disorder, defined as

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
SEA-CD70
2
TS-161 (50 - 100 mg)
1
Unaided condition

Trial Design

2 Treatment Groups

Dosing as usual (DAU) group
1 of 2
PSY-PGx Group
1 of 2

Active Control

Experimental Treatment

2500 Total Participants · 2 Treatment Groups

Primary Treatment: PSY-PGx Group · No Placebo Group · N/A

PSY-PGx Group
Other
Experimental Group · 1 Intervention: Personalised medication advice based on pharmacogenetic testing · Intervention Types: Other
Dosing as usual (DAU) groupNoIntervention Group · 1 Intervention: Dosing as usual (DAU) group · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24 weeks

Who is running the clinical trial?

Maastricht UniversityLead Sponsor
203 Previous Clinical Trials
12,148,699 Total Patients Enrolled
Parnassia Psychiatric InstituteUNKNOWN
King's College LondonOTHER
626 Previous Clinical Trials
11,741,202 Total Patients Enrolled
2 Trials studying Mood Disorders
109 Patients Enrolled for Mood Disorders
University of BarcelonaOTHER
113 Previous Clinical Trials
51,216 Total Patients Enrolled
Ludwig-Maximilians - University of MunichOTHER
331 Previous Clinical Trials
18,038,611 Total Patients Enrolled
1 Trials studying Mood Disorders
584 Patients Enrolled for Mood Disorders
University of BonnOTHER
40 Previous Clinical Trials
30,870 Total Patients Enrolled
Babes-Bolyai UniversityOTHER
35 Previous Clinical Trials
8,419 Total Patients Enrolled
University of BelgradeOTHER
64 Previous Clinical Trials
50,048 Total Patients Enrolled
State University of New York - Upstate Medical UniversityOTHER
157 Previous Clinical Trials
24,254 Total Patients Enrolled
Bea Campforts, MscPrincipal InvestigatorMaastricht University
Roos van Westrhenen, Ass. Prof.Principal InvestigatorParnassia Psychiatric Institute (Amsterdam)
Therese van Amelsvoort, Prof. Dr.Principal InvestigatorMaastricht University, Department of Psychiatry and Neuropsychology

Eligibility Criteria

Age 16 - 65 · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You need to have a smartphone (either Android or iOS) for passive monitoring.
References

Frequently Asked Questions

Is eligibility for this research project confined to individuals below the age of 45?

"This clinical trial's parameters stipulate that the participating patient must be between 16 and 65 years of age. Simultaneously, there are 422 studies being conducted for minors and 1033 trials taking place with seniors as participants." - Anonymous Online Contributor

Unverified Answer

Is enrollment into this experiment still open?

"According to records hosted on clinicaltrials.gov, this specific trial is no longer recruiting participants; the initial post date was December 1st 2022 with a recent update occurring on the 9th of that month. Fortunately, there are presently 1588 other trials searching for volunteers across the world." - Anonymous Online Contributor

Unverified Answer

Is it possible to join this medical experiment?

"This trial is seeking 2500 individuals aged 16 to 65 who suffer from a mental health condition, such as major depressive disorder, bipolar disorder (with current episode of depression), panic disorder or generalised anxiety disorder. Such participants must have had an inadequate response to at least one psychotropic treatment and are currently receiving inpatient or outpatient psychiatric care. Furthermore, they should be willing to switch their medication either sertraline/escitalopram for mood/anxiety disorders or aripiprazole/risperidone for psychotic disorders within the last 2 weeks prior to contact with an investigator. Finally, applicants need possess basic understanding about this" - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top